Showing results (141-150 of 183) with videos related to
Sort By:
Pageof 19
The American Journal of Cardiology|December 5, 1997
Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen KrankenhausärtzeR Zahn, J Rustige, A Koch, et al.European Heart Journal|September 11, 2001
Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR)M Gottwik, R Zahn, R Schiele, et al.American Heart Journal|June 30, 2001
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysisR Zahn, R Schiele, A K Gitt, et al.Zeitschrift Fur Kardiologie|August 7, 2001
[Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct]H Wienbergen, R Schiele, A K Gitt, et al.Heart (British Cardiac Society)|August 1, 2007
Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)R Zahn, M Gottwik, M Hochadel, et al.Zeitschrift Fur Kardiologie|October 28, 2003
Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarctionM Kentsch, U Rodemerk, A K Gitt, et al.Journal of the American College of Cardiology|June 13, 2001
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction RegistryR Zahn, R Schiele, S Schneider, et al.Gene Therapy|March 1, 2000
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veinsP Boekstegers, G von Degenfeld, W Giehrl, et al.The American Journal of Cardiology|March 16, 2001
Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice. MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial InfarctionH Wienbergen, R Schiele, A K Gitt, et al.Herz|January 6, 2001
Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)R Zahn, R Schiele, S Schneider, et al.Pageof 19